Teva Pharms Usa Company Profile

✉ Email this page to a colleague

TEVA PHARMS USA has one hundred and ninety-six approved drugs.

There are twenty-nine tentative approvals on TEVA PHARMS USA drugs.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Pharms Usa	TENOFOVIR DISOPROXIL FUMARATE	tenofovir disoproxil fumarate	TABLET;ORAL	091612-001	Mar 18, 2015	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Teva Pharms Usa	VANCOMYCIN HYDROCHLORIDE	vancomycin hydrochloride	INJECTABLE;INJECTION	201250-001	Dec 23, 2015		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Teva Pharms Usa	TREPROSTINIL	treprostinil	INJECTABLE;IV (INFUSION), SUBCUTANEOUS	206648-004	Sep 26, 2019	AP	RX	No	No		⤷ Sign Up				⤷ Sign Up
Teva Pharms Usa	ESCITALOPRAM OXALATE	escitalopram oxalate	TABLET;ORAL	076765-003	Mar 14, 2012		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Teva Pharms Usa	OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil	TABLET;ORAL	202491-004	Nov 3, 2016	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Teva Pharms Usa	PALIPERIDONE PALMITATE	paliperidone palmitate	SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR	211149-005	Jul 6, 2021	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Teva Pharms Usa	DEFERASIROX	deferasirox	TABLET;ORAL	209223-001	Nov 25, 2019		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Pharms Usa	COPAXONE	glatiramer acetate	INJECTABLE;SUBCUTANEOUS	020622-003	Jan 28, 2014	6,054,430	⤷ Sign Up
Teva Pharms Usa	COPAXONE	glatiramer acetate	INJECTABLE;SUBCUTANEOUS	020622-002	Feb 12, 2002	6,939,539	⤷ Sign Up
Teva Pharms Usa	COPAXONE	glatiramer acetate	INJECTABLE;SUBCUTANEOUS	020622-002	Feb 12, 2002	6,620,847	⤷ Sign Up
Teva Pharms Usa	COPAXONE	glatiramer acetate	FOR SOLUTION;SUBCUTANEOUS	020622-001	Dec 20, 1996	5,981,589	⤷ Sign Up
Teva Pharms Usa	COPAXONE	glatiramer acetate	INJECTABLE;SUBCUTANEOUS	020622-003	Jan 28, 2014	8,367,605	⤷ Sign Up
Teva Pharms Usa	COPAXONE	glatiramer acetate	FOR SOLUTION;SUBCUTANEOUS	020622-001	Dec 20, 1996	6,362,161	⤷ Sign Up
Teva Pharms Usa	COPAXONE	glatiramer acetate	FOR SOLUTION;SUBCUTANEOUS	020622-001	Dec 20, 1996	6,620,847	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03
➤ Subscribe	Injection	40 mg/mL, 1 mL pre-filled syringe	➤ Subscribe	2014-02-26
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	Injection	40 mg/mL, 1 mL pre-filled syringe	➤ Subscribe	2014-01-29
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.